The Technical Analyst
Biomerica Inc [BMRA]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Biomerica Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
2.96% $0.773
America/New_York / 18 apr 2024 @ 13:27
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 13.00 mill |
| EPS: | -0.370 |
| P/E: | -2.09 |
| Earnings Date: | Apr 14, 2024 |
| SharesOutstanding: | 16.82 mill |
| Avg Daily Volume: | 0.0573 mill |
| RATING 2024-04-18 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -2.09 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -2.09 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.681 - 0.865 ( +/- 11.91%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-13 | Coste Catherine | Buy | 75 000 | Non-qualified stock option |
| 2023-12-13 | Moatazedi David | Buy | 75 000 | Non-qualified stock option |
| 2023-12-13 | Kenny John P. | Buy | 75 000 | Non-qualified stock option |
| 2023-12-13 | Emerson Jane | Buy | 75 000 | Non-qualified stock option |
| 2023-12-13 | Lu Gary | Buy | 155 000 | Non-qualified stock option |
| INSIDER POWER |
|---|
| 100.00 |
| Last 96 transactions |
| Buy: 2 712 565 | Sell: 242 000 |
Forecast:
15:14 - $0.767
Live Trading Signals (every 1 min)
Forecast
1: 13:44 - $0.770
Forecast 2: 14:34 - $0.771
Forecast 3: 15:14 - $0.767
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.773 (2.96% ) |
| Volume | 0.0295 mill |
| Avg. Vol. | 0.0573 mill |
| % of Avg. Vol | 51.43 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BMRA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:15 | sell | $0.890 | N/A | Active |
|---|
BMRA
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Latest Press Releases
2024-04-15 07:47:00 - Press Release
Biomerica Provides Update On Infoods® Ibs Expansion
- expansion into new offices within current major groups, including northeast and ohio; expansion into new major group in texas.
2024-04-12 19:23:00 - Press Release
Biomerica Reports Third Quarter 2024 Financial Results
Irvine, calif., april 12, 2024 (globe newswire) -- biomerica, inc. (nasdaq: bmra), (the “company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2024 ended february 29, 2024.
2024-03-28 08:19:00 - Press Release
Biomerica Infoods Ibs Data To Be Presented At The Upcoming Digestive Disease Week (ddw) 2024 Conference
Irvine, calif., march 28, 2024 (globe newswire) -- biomerica, inc. (nasdaq: bmra), a global biomedical company at the forefront of innovative gastroenterology solutions, proudly announces that data from collaborators at the university of michigan utilizing its groundbreaking infoods ibs technologies will be presented in the ibs clinical session at the 2024 digestive disease week (ddw) annual meeting in washington dc. ddw is renowned as the world's premier scientific and clinical meeting for digestive disease health care professionals.
2024-02-21 08:19:00 - Press Release
Diagnostics Industry Leader Gary Huff Appointed To Biomerica Strategic Advisory Board
Mr. huff was the former ceo of labcorp diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare mr. huff was the former ceo of labcorp diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare
2024-01-23 08:19:00 - Press Release
Diagnostics Industry Leader Jack Kenny Appointed As Chairman Of The Board At Biomerica
Irvine, calif., jan. 23, 2024 (globe newswire) -- biomerica, inc. (nasdaq: bmra), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of jack kenny, former ceo and board member of meridian bioscience, inc., to serve as the chairman of the board of directors of biomerica. mr. zack irani will continue to serve as ceo. mr. kenny joined the biomerica board of directors in august 2023 as an independent director.
Latest News
2022-10-14 09:46:54 - Market Watch
Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores
Shares of Biomerica Inc. BMRA, +7.58% shot up 13.1% toward a 6-month high in active morning trading Friday, after the medical diagnostic products company said Walmart Inc. WMT, +0.45% will start selling its Aware Breast Self Exam device in about half its stores. Trading volume ballooned to 1.8 million shares, compared with the full-day average of about 57,200 shares.
2022-07-14 11:59:03 - Benzinga
Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices
Biomerica Inc (NASDAQ: BMRA) announced that its Aware Breast Self Exam device will now be sold in Walmart Inc's (NYSE: WMT) retail system. The Biomerica FDA-cleared Aware Breast Self Exam device is a way for women to enhance tactile sensitivity to changes or.
2021-10-19 07:34:47 - Benzinga
Recap: Biomerica Q1 Earnings
Biomerica(NASDAQ:BMRA) stock rose by 2.53% on Monday after the company reported its Q1 earnings results on Friday, October 15, 2021 at 06:30 AM. Here's what investors need to know about the announcement.
2021-10-19 06:39:00 - GlobeNewsWire
Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Screening Test
IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has begun in-store sales and rollout of the Company's EZ Detect™ colorectal disease screening test within the nationwide Walmart retail system. Biomerica has shipped the EZ Detect product to Walmart distribution centers in the US and product is projected to be on the shelf in over 4,600 Walmart Stores nationwide over the next two weeks. The in-store retail placement follows Biomerica's previous announcement in early October, that Walmart had begun sales of EZ Detect™ product for online purchase through Walmart.com (https://www.walmart.com/ip/EZ-Detect-Colon-Disease-Test-Kit/577079744)...
2021-10-15 06:39:00 - GlobeNewsWire
Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021
IRVINE, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its first quarter fiscal 2022 financial results.
2021-10-05 14:25:22 - Pulse2
BMRA Stock: Why It Increased Drastically Today
The stock price of Biomerica, Inc. (NASDAQ: BMRA) increased by over 19% during intraday trading today. This is why it happened.
2021-10-04 12:43:33 - InvestorPlace
Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to Pop
According to Fintel, here are five short squeeze stocks that are among the most likely to see a squeeze attempt moving forward. The post Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to Pop appeared first on InvestorPlace.
2021-10-04 10:31:56 - Benzinga
5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted strong interest and saw shares spike. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
2021-10-02 14:13:10 - Pulse2
BMRA Stock Price: Why It Increased 38%
The stock price of Biomerica, Inc. (NASDAQ: BMRA) increased by 38% in the previous trading session. This is why it happened.
2021-10-01 11:00:09 - InvestorPlace
BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today
Biomerica (BMRA) stock is surging higher on Friday thanks to a new deal with Walmart (WMT) concerning its EZ Detect product. The post BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today appeared first on InvestorPlace.